Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
1998-9-29
pubmed:abstractText
Primary CNS lymphoma (PCNSL) and primary intraocular lymphoma (IOL) are usually treated with radiation therapy alone or in combination with chemotherapy. The neurotoxicity of these treatments can be substantial. This study attempts to define the toxicity and efficacy of the treatment of this disease with chemotherapy alone.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0732-183X
pubmed:author
pubmed:issnType
Print
pubmed:volume
16
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3000-6
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:9738568-Adult, pubmed-meshheading:9738568-Aged, pubmed-meshheading:9738568-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:9738568-Central Nervous System Neoplasms, pubmed-meshheading:9738568-Cytarabine, pubmed-meshheading:9738568-Dexamethasone, pubmed-meshheading:9738568-Drug Administration Schedule, pubmed-meshheading:9738568-Eye Neoplasms, pubmed-meshheading:9738568-Female, pubmed-meshheading:9738568-Humans, pubmed-meshheading:9738568-Leucovorin, pubmed-meshheading:9738568-Lymphoma, B-Cell, pubmed-meshheading:9738568-Lymphoma, Large B-Cell, Diffuse, pubmed-meshheading:9738568-Male, pubmed-meshheading:9738568-Methotrexate, pubmed-meshheading:9738568-Middle Aged, pubmed-meshheading:9738568-Pilot Projects, pubmed-meshheading:9738568-Thiotepa, pubmed-meshheading:9738568-Vincristine
pubmed:year
1998
pubmed:articleTitle
Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma.
pubmed:affiliation
Medicine and Pediatric Branches, Department of Neurosurgery, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-2440, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Clinical Trial, Phase II